Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Interview
Spotlight Article

Vector production in academia: obstacles and opportunities

Viral vector bioprocessing & analytics: today’s key tools and innovation requirements to meet future demand

DANIELA BISCHOF is an Assistant Professor of Clinical Medical and Molecular Genetics, and Director of Vector Production at the Indiana University School of Medicine. She has almost 20 years of experience in the field of gene therapy and has been involved in the production of clinical grade gene therapy lentiviral and retroviral products since 2007.

EMILY HOPEWELL is the Director of Cell and Gene Therapy Manufacturing and an Assistant Professor in Clinical Medical and Molecular Genetics at Indiana University, and is charged with implementing and building manufacturing for cell, gene, and immune therapy at Indiana University.

DOI: 10.18609/cgti.2020.036
Citation: Cell & Gene Therapy Insights 2020; 6(3), 267- 273
Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog